Transcriptome-based classification to predict FOLFIRINOX response in a real-world metastatic pancreatic cancer cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transcriptome-based classification to predict FOLFIRINOX response in a real-world metastatic pancreatic cancer cohort

Published:2024-11 Issue: Volume:273 Page:137-147
ISSN:1931-5244
Container-title:Translational Research
language:en
Short-container-title:Translational Research

Author:

Lansbergen Marjolein F.^ORCID,Dings Mark P.G.,Manoukian Paul,Fariña Arantza,Waasdorp Cynthia,Hooijer Gerrit K.J.,Verheij Joanne,Koster Jan,Zwijnenburg Danny A.,Wilmink Johanna W.,Medema Jan Paul,Dijk Frederike,van Laarhoven Hanneke W.M.,Bijlsma Maarten F.

Funder

Horizon 2020 MSCA

Horizon 2020 Framework Programme

ZonMw

Publisher

Elsevier BV

Reference49 articles.

1. Estimated Projection of US Cancer Incidence and Death to 2040;Rahib;JAMA Netw Open,2021

2. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma;Latenstein;Eur J Cancer,2020

3. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

4. First- and Second-Line Palliative Systemic Treatment Outcomes in a Real-World Metastatic Pancreatic Cancer Cohort;Pijnappel;J Natl Compr Canc Netw,2021

5. NAPOLI-3: A randomized, open-label phase 3 study of liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naïve patients with metastatic pancreatic ductal adenocarcinoma (mPDAC);Wainberg;Journal of Clinical Oncology,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP